Article
High-throughput RNAi screen identifies ILK as a target to overcome intrinsic EGFR-TKI resistance of lung squamous carcinoma
2019-11-19
Abstract excerpt
<title>Abstract</title> <p>Although targeted therapy has made a significant efficacy in lung adenocarcinoma, there are still no effective targeted drugs for lung squamous cell carcinoma (SqCC). Moreover, immunotherapy only prolonged the OS of lung SqCC for less than 5 months, so till now, chemotherapy and radiotherapy are still the main treatments of advanced SqCC. Lung SqCC patients express higher epithelial gro...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1ddd1697-df1b-53ee-8fd0-142e6b63b680
- DOI
- 10.21203/rs.2.17492/v1
